A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of Synthetic PreImplantation Factor (sPIF) in Autoimmune Hepatitis
Phase of Trial: Phase I
Latest Information Update: 02 May 2017
At a glance
- Drugs Preimplantation factor (Primary)
- Indications Autoimmune hepatitis
- Focus Adverse reactions
- 25 Apr 2017 Status changed from recruiting to completed.
- 20 Nov 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Feb 2017.
- 01 Aug 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Sep 2016.